SARS-CoV-2 Quality Solutions


LGC SeraCare has provided gold standard third-party run controls and reference materials to clinical laboratories for more than 30 years. We are committed to supporting the critical efforts of assay development, verification, and ongoing performance monitoring in response to the COVID-19 pandemic. Our quality solutions encompass both molecular and serology performance monitoring tools to support early detection of infection and antibody surveillance efforts.

Learn more about our 
SARS-CoV-2 Molecular (PCR) and Serology solutions


Learn more about our SARS-CoV-2, Flu A/B, and RSV multiplexed solutions



The Native Antigen Company is now part of the LGC Clinical Diagnostics Division and specializes in the development and manufacture of native and recombinant viral and bacterial antigens and antibodies. The Company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system which ensures correct glycosylation and proper folding for the development of highly specific assays. For more information on The Native Antigen Company visit:

Learn more New SARS-CoV-2 Spike Monoclonal Antibodies solutions


*clicking on the above button will direct you to LGC's The Native Antigen Company website to learn more.